Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcelo Kremenchutzky

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 23, 2011
Safety, not only efficacy still to be proven for controversial new MS treatmentMarcelo Kremenchutzky
Neurology|November 12, 2003
Long-term evolution of anti-INFbeta antibodies in IFNbeta-treated MS patients: the London, Canada, MS Clinic experienceMarcelo Kremenchutzky
The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses|February 22, 2014
Pegylated interferons: a nurses' review of a novel multiple sclerosis therapyAnne Howley, Marcelo Kremenchutzky
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 20, 2013
Perceptions of health status in multiple sclerosis patients and their doctorsMarcelo Kremenchutzky, Len Walt
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|October 28, 2015
Use of Natalizumab in Patients with Multiple Sclerosis: 2015 UpdatePaul W O'Connor, Marcelo Kremenchutzky
Expert Opinion on Drug Safety|May 8, 2007
The safety and efficacy of IFN-beta products for the treatment of multiple sclerosisMarcelo Kremenchutzky, Sarah Morrow, Carolina Rush
Multiple Sclerosis and Related Disorders|May 27, 2015
Systematic review of efficacy of TENS for management of central pain in people with multiple sclerosisAnuradha Sawant, Kelly Dadurka, Tom Overend, et al.
Advances in Neurology|January 13, 2006
The natural history of multiple sclerosisRajas Deshpande, Marcelo Kremenchutzky, George P A Rice
Frontiers in Neurology|July 26, 2013
Venocentric Lesions: An MRI Marker of MS?Matthew P Quinn, Marcelo Kremenchutzky, Ravi S Menon
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 14, 2016
Breaking down the gut microbiome composition in multiple sclerosisAdrian Budhram, Seema Parvathy, Marcelo Kremenchutzky, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 23, 2011
Safety, not only efficacy still to be proven for controversial new MS treatmentMarcelo Kremenchutzky
Neurology|November 12, 2003
Long-term evolution of anti-INFbeta antibodies in IFNbeta-treated MS patients: the London, Canada, MS Clinic experienceMarcelo Kremenchutzky
The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses|February 22, 2014
Pegylated interferons: a nurses' review of a novel multiple sclerosis therapyAnne Howley, Marcelo Kremenchutzky
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 20, 2013
Perceptions of health status in multiple sclerosis patients and their doctorsMarcelo Kremenchutzky, Len Walt
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|October 28, 2015
Use of Natalizumab in Patients with Multiple Sclerosis: 2015 UpdatePaul W O'Connor, Marcelo Kremenchutzky
Expert Opinion on Drug Safety|May 8, 2007
The safety and efficacy of IFN-beta products for the treatment of multiple sclerosisMarcelo Kremenchutzky, Sarah Morrow, Carolina Rush
Multiple Sclerosis and Related Disorders|May 27, 2015
Systematic review of efficacy of TENS for management of central pain in people with multiple sclerosisAnuradha Sawant, Kelly Dadurka, Tom Overend, et al.
Advances in Neurology|January 13, 2006
The natural history of multiple sclerosisRajas Deshpande, Marcelo Kremenchutzky, George P A Rice
Frontiers in Neurology|July 26, 2013
Venocentric Lesions: An MRI Marker of MS?Matthew P Quinn, Marcelo Kremenchutzky, Ravi S Menon
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 14, 2016
Breaking down the gut microbiome composition in multiple sclerosisAdrian Budhram, Seema Parvathy, Marcelo Kremenchutzky, et al.
Pageof 4